Sanara MedTech (SMTI) Receivables - Net (2010 - 2026)

Sanara MedTech's Receivables - Net history runs 17 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• Quarterly Receivables - Net rose 31702.25% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 31702.25% YoY) and the FY2025 annual result came in at $12.0 million, down 3.31% from the prior year.
• Receivables - Net was $13.6 million for Q1 2026 at Sanara MedTech, up from $12.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $13.6 million in Q1 2026 and bottomed at $20662.0 in Q2 2023.
• A 5-year average of $6.8 million and a median of $7.4 million in 2023 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net plunged 99.46% — and 2024, when it soared 50697.32%.
• Sanara MedTech's Receivables - Net stood at $6.8 million in 2022, then gained by 24.53% to $8.5 million in 2023, then jumped by 46.42% to $12.4 million in 2024, then declined by 3.31% to $12.0 million in 2025, then grew by 13.5% to $13.6 million in 2026.
• Business Quant data shows SMTI's Receivables - Net at $13.6 million in Q1 2026, $12.0 million in Q4 2025, and $12.1 million in Q3 2025.